NEW YORK (GenomeWeb News) – GE has launched a new $250 million equity fund to invest in "highly promising" young companies developing or offering life sciences tools, diagnostics, and health care information technologies, GE Healthcare said today.

The GE Healthymagination Fund, part of the company's $6 billion Healthymagination Initiative, will be global in reach and it will harness the capabilities of GE Healthcare, GE Capital, and GE Global Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.